Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung
Position
Vice President
Company
Bristol Myers Squibb
PrincetonManufacturingBiotechnologyProfessional ServicesHealth CareMedicalTherapeuticsPharmaceuticalLegalBiopharmaLaw EnforcementDescription
Sandra Leung, the executive president and general counsel at Bristol-Myers Squibb, will retire from her position during 2025, with Cari Gallman set to succeed her in the role of executive vice president, general counsel, and chief policy officer. The transition is expected to occur later this year, with Leung remaining to help with the duties transition.
Quick answer
Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025). Bristol Myers Squibb is based in Princeton, New Jersey, United States.
- Who is the new Vice President at Bristol Myers Squibb?
- Bristol Myers Squibb named Cari Gallman Vice President, announced February 21, 2025.
- What did Bristol Myers Squibb announce on February 21, 2025?
- Sandra Leung, the executive president and general counsel at Bristol-Myers Squibb, will retire from her position during 2025, with Cari Gallman set to succeed her in the role of executive vice president, general counsel, and chief policy officer. The transition is expected to occur later this year, with Leung remaining to help with the duties transition.
- What does Bristol Myers Squibb do?
- Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
- Where is Bristol Myers Squibb based?
- Bristol Myers Squibb is based in Princeton, New Jersey, United States.
- Which similar companies made leadership changes around the same time?
- Cerenome, Inc. (February 24, 2025), Pfizer (February 24, 2025), Crinetics Pharmaceuticals (February 26, 2025) and Santhera Pharmaceuticals (February 10, 2025) also announced leadership changes within 45 days of Bristol Myers Squibb.
Source: Fundz verified event record.
Other recent leadership changes in Professional Services and Medical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Plus Therapeutics Appoints Michael Rosol, Ph.D., as Chief Development Officer (February 24, 2025)
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Santhera Pharmaceuticals Appoints Catherine Isted as CFO, Andrew Smith to Step Down (February 10, 2025)
- Daiichi Sankyo Names Hiroyuki Okuzawa as Chief Executive Officer (CEO) succeeding Sunao Manabe (January 31, 2025)
- Acrivon Therapeutics Appoints Adam Levy, Ph.D., M.B.A. as Chief Financial Officer (March 14, 2025)
Who to call at Bristol Myers Squibb, and when
A new leader at Bristol Myers Squibb brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Bristol Myers Squibb raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bristol Myers Squibb, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bristol Myers Squibb. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bristol Myers Squibb changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bristol Myers Squibb changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.